Chuck Royce's DFTX Position Overview
Chuck Royce (via Royce & Associates Lp) currently holds 234,051 shares of Definium Therapeutics, Inc. (DFTX) worth $4.42 M, representing 0.04% of the portfolio. First purchased in 2026-Q1, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Chuck Royce has initiated a new position in DFTX, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Chuck Royce's Definium Therapeutics (DFTX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Definium Therapeutics (DFTX) Trades by Chuck Royce
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +234,051 | New Buy | 234,051 | $18.90 |
Chuck Royce's Definium Therapeutics Investment FAQs
Chuck Royce first purchased Definium Therapeutics, Inc. (DFTX) in Q1 2026, acquiring 234,051 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Chuck Royce has held Definium Therapeutics, Inc. (DFTX) for 1 quarters since Q1 2026.
Chuck Royce's largest addition to Definium Therapeutics, Inc. (DFTX) was in Q1 2026, adding 234,051 shares worth $4.42 M.
According to the latest 13F filing for Q1 2026, Chuck Royce's firm, Royce & Associates Lp, owns 234,051 shares of Definium Therapeutics, Inc. (DFTX), valued at approximately $4.42 M.
As of the Q1 2026 filing, Definium Therapeutics, Inc. (DFTX) represents approximately 0.04% of Chuck Royce's publicly disclosed stock portfolio, making it one of their key holdings.
Chuck Royce's peak holding in Definium Therapeutics, Inc. (DFTX) was 234,051 shares, as reported at the end of Q1 2026.